High frequency of MRSA in surgical site infections and elevated vancomycin MIC

Wound Medicine

Volumn 17, Issue , 2017, Pages 7-10

  Akhi, Mohammad Taghi ^a,b   Ghotaslou, Reza ^a,b   Alizadeh, Naser ^a,b   pirzadeh, Tahereh ^b   Beheshtirouy, Samad ^b   Memar, Mohammad Yousef ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Methicillin resistant Staphylococcus aureu; Minimum inhibition concentration; Surgical site infections; Vancomycin

Indexed keywords

CEFOXITIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; OXACILLIN; PSEUDOMONIC ACID; VANCOMYCIN;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DISK DIFFUSION; EPSILOMETER TEST; HOSPITAL PATIENT; HUMAN; IRAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR GENETICS; MORTALITY; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; RESPIRATORY TRACT INFECTION; SURGICAL INFECTION; WOUND INFECTION;

EID: 85012280060     PISSN: 22139095     EISSN: 22139109     Source Type: Journal    
DOI: 10.1016/j.wndm.2017.01.002     Document Type: Article

References (31)

1. [1] Eriksen, H., Chugulu, S., Kondo, S., Lingaas, E., Surgical-site infections at kilimanjaro christian medical center. J. Hosp. Infect. 55:1 (2003), 14–20.
2. [2] Reddy, B.R., Management of culture-negative surgical site infections. J. Med. Allied Sci., 2(1), 2012.
3. [3] Giacometti, A., Cirioni, O., Schimizzi, A., Del Prete, M., Barchiesi, F., D'errico, M., Petrelli, E., Scalise, G., Epidemiology and microbiology of surgical wound infections. J. Clin. Microbiol. 38:2 (2000), 918–922.
4. [4] Engemann, J.J., Carmeli, Y., Cosgrove, S.E., Fowler, V.G., Bronstein, M.Z., Trivette, S.L., Briggs, J.P., Sexton, D.J., Kaye, K.S., Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Infect. Dis. 36:5 (2003), 592–598.
5. [5] Shore, A.C., Deasy, E.C., Slickers, P., Brennan, G., O'Connell, B., Monecke, S., Ehricht, R., Coleman, D.C., Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Antimicrob. Gents Chemother. 55:8 (2011), 3765–3773.
6. [6] Nichols, R.L., Florman, S., Clinical presentations of soft-tissue infections and surgical site infections. Clin. Infect. Dis. 33:Suppl. 2 (2001), S84–S93.
7. [7] Tenover, F.C., Biddle, J.W., Lancaster, M.V., Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg. Infect. Dis., 7(2), 2001, 327.
8. [8] Satola, S., Lessa, F., Ray, S., Bulens, S., Lynfield, R., Schaffner, W., Dumyati, G., Nadle, J., Patel, J., Clinical and laboratory characteristics of invasive infections due to methicillin-resistant Staphylococcus aureus isolates demonstrating a vancomycin MIC of 2 micrograms per milliliter: lack of effect of heteroresistant vancomycin-intermediate S. aureus phenotype. J. Clin. Microbiol. 49:4 (2011), 1583–1587.
9. [9] Connie, R., Mahon, D., Lehman, C., Manuselis, G., Textbook of Diagnostic Microbiology. 2011, WB Saunder, UK, 502–537.
10. [10] Wayne, P., Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing 21. 2011.
11. [11] Asgharzadeh, M., Kafil, H.S., Khakpour, M., Comparison of mycobacterial interspersed repetitive unit-variable number tandem repeat and IS6110-RFLP methods in identifying epidemiological links in patients with tuberculosis in Northwest of Iran. Annals Microbiol. 58:2 (2008), 333–339.
12. [12] Sadeghi, J., Mansouri, S., Molecular characterization and antibiotic resistance of clinical isolates of methicillin-resistant Staphylococcus aureus obtained from Southeast of Iran (Kerman). APMIS 122:5 (2014), 405–411.
13. [13] Negi, V., Pal, S., Juyal, D., Sharma, M.K., Sharma, N., Bacteriological profile of surgical site infections and their antibiogram: a study from resource constrained rural setting of uttarakhand state, India. J. Clin. Diagn. Res. JCDR, 9(10), 2015, DC17.
14. [14] Yang, Z., Wang, J., Wang, W., Zhang, Y., Han, L., Zhang, Y., Nie, X., Zhan, S., Proportions of staphylococcus aureus and methicillin-resistant staphylococcus aureus in patients with surgical site infections in mainland China: a systematic review and meta-analysis. PLoS One, 10(1), 2015, e0116079.
15. [15] Iyamba, J.-M.L., Wambale, J.M., Lukukula, C.M., High prevalence of methicillin resistant staphylococci strains isolated from surgical site infections in Kinshasa. Pan Afr. Med. J., 18, 2014.
16. [16] Kassavin, D.S., Pascarella, L., Goldfarb, M.A., Surgical site infections: incidence and trends at a community teaching hospital. Am. J. Surg. 201:6 (2011), 749–753.
17. [17] Seni, J., Najjuka, C.F., Kateete, D.P., Makobore, P., Joloba, M.L., Kajumbula, H., Kapesa, A., Bwanga, F., Antimicrobial resistance in hospitalized surgical patients: a silently emerging public health concern in Uganda. BMC Res. Notes, 6(1), 2013, 298.
18. [18] Múñez, E., Ramos, A., Álvarez de Espejo, T., Vaqué, J., Sánchez-Payá, J., Pastor, V., Asensio, Á., Microbiology of surgical site infections in abdominal tract surgery patients. Cirugía Española (English Edition) 89:9 (2011), 606–612.
19. [19] Taylor, M.D., Napolitano, L.M., Methicillin-resistant Staphylococcus aureus infections in vascular surgery: increasing prevalence. Surg. Infect. 5:2 (2004), 180–187.
20. [20] Amare, B., Abdurrahman, Z., Moges, B., Ali, J., Muluken, L., Alemayehu, M., Yifru, S., Sendek, B., Belyhun, Y., Moges, F., Postoperative surgical site bacterial infections and drug susceptibility patterns at Gondar University Teaching Hospital, Northwest Ethiopia. J. Bacteriol. Parasitol., 2011, 2012.
21. [21] Manian, F.A., Meyer, P.L., Setzer, J., Senkel, D., Surgical site infections associated with methicillin-resistant Staphylococcus aureus: do postoperative factors play a role?. Clin. Infect. Dis. 36:7 (2003), 863–868.
22. [22] Tacconelli, E., De Angelis, G., Cataldo, M.A., Pozzi, E., Cauda, R., Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J. Antimicrob. Chemother. 61:1 (2008), 26–38.
23. [23] Kahsay, A., Mihret, A., Abebe, T., Andualem, T., Isolation and antimicrobial susceptibility pattern of Staphylococcus aureus in patients with surgical site infection at Debre Markos Referral Hospital, Amhara Region, Ethiopia. Arch Public Health, 72, 2014, 16.
24. [24] Tiwari, H.K., Sapkota, D., Sen, M.R., High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India. Infect. Drug Resistance 1 (2008), 57–61.
25. [25] Lodise, T., Graves, J., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B., Stellrecht, K., Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob. Agents Chemother. 52:9 (2008), 3315–3320.
26. [26] Steinkraus, G., White, R., Friedrich, L., Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 to 05. J. Antimicrob. Chemother. 60:4 (2007), 788–794.
27. [27] Edwards, B., Milne, K., Lawes, T., Cook, I., Robb, A., Gould, I., Is vancomycin MIC creep method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010. J. Clin. Microbiol. 50:2 (2012), 318–325.
28. [28] Choi, E.Y., Huh, J.W., Lim, C.-M., Koh, Y., Kim, S.-H., Choi, S.-H., Kim, Y.S., Kim, M.-N., Hong, S.-B., Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia. Intensive Care Med. 37:4 (2011), 639–647.
29. [29] Sharpe, J.N., Shively, E.H., Polk, H.C., Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. Am. J. Surg. 189:4 (2005), 425–428.
30. [30] Weigelt, J., Itani, K., Stevens, D., Lau, W., Dryden, M., Knirsch, C., Group, L.C.S., Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob. Agents Chemother. 49:6 (2005), 2260–2266.
31. [31] Young, L.S., Winston, L.G., Preoperative use of mupirocin for the prevention of healthcare-associated Staphylococcus aureus infections: a cost-effectiveness analysis. Infect. Control 27:12 (2006), 1304–1312.